DK3334454T3 - Mycoplasma-Bovis-sammensætninger - Google Patents

Mycoplasma-Bovis-sammensætninger Download PDF

Info

Publication number
DK3334454T3
DK3334454T3 DK16757118.1T DK16757118T DK3334454T3 DK 3334454 T3 DK3334454 T3 DK 3334454T3 DK 16757118 T DK16757118 T DK 16757118T DK 3334454 T3 DK3334454 T3 DK 3334454T3
Authority
DK
Denmark
Prior art keywords
assemblages
bovis
mycoplasma
bovis assemblages
Prior art date
Application number
DK16757118.1T
Other languages
English (en)
Inventor
Glenn Francis Browning
Philip Francis Markham
Marc Serge Marenda
Fred H Weber
Suman Mahan
Original Assignee
Zoetis Services Llc
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc, Univ Melbourne filed Critical Zoetis Services Llc
Application granted granted Critical
Publication of DK3334454T3 publication Critical patent/DK3334454T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK16757118.1T 2015-08-14 2016-08-11 Mycoplasma-Bovis-sammensætninger DK3334454T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562205125P 2015-08-14 2015-08-14
PCT/US2016/046572 WO2017030901A1 (en) 2015-08-14 2016-08-11 Mycoplasma bovis compositions

Publications (1)

Publication Number Publication Date
DK3334454T3 true DK3334454T3 (da) 2022-11-14

Family

ID=56800367

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16757118.1T DK3334454T3 (da) 2015-08-14 2016-08-11 Mycoplasma-Bovis-sammensætninger

Country Status (23)

Country Link
US (2) US11389518B2 (da)
EP (2) EP3334454B1 (da)
JP (1) JP6675484B2 (da)
CN (3) CN115141773A (da)
AU (2) AU2016307935B2 (da)
BR (1) BR112018002919B1 (da)
CA (1) CA2995101A1 (da)
CY (2) CY1125699T1 (da)
DK (1) DK3334454T3 (da)
ES (1) ES2933623T3 (da)
FI (1) FI3334454T3 (da)
FR (1) FR23C1037I1 (da)
HK (1) HK1251478A1 (da)
HR (1) HRP20221440T1 (da)
HU (2) HUE060545T2 (da)
LT (1) LT3334454T (da)
MX (1) MX2018001841A (da)
NL (1) NL301244I2 (da)
PL (1) PL3334454T3 (da)
PT (1) PT3334454T (da)
SI (1) SI3334454T1 (da)
WO (1) WO2017030901A1 (da)
ZA (1) ZA201800956B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109022314B (zh) * 2018-08-06 2021-08-13 北京华夏兴洋生物科技有限公司 一株牛支原体及其在疫苗研制中的应用
CN111471695A (zh) * 2020-05-11 2020-07-31 吉林农业大学 牛支原体免疫磁珠的制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5174993A (en) 1981-12-24 1992-12-29 Health Research Inc. Recombinant avipox virus and immunological use thereof
US5505941A (en) 1981-12-24 1996-04-09 Health Research, Inc. Recombinant avipox virus and method to induce an immune response
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5078996A (en) 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
KR100242671B1 (ko) 1991-03-07 2000-03-02 고돈 에릭 유전학적으로 처리한 백신 균주
IL101715A (en) 1991-05-02 2005-06-19 Amgen Inc Recombinant dna-derived cholera toxin subunit analogs
JPH07507854A (ja) 1991-12-23 1995-08-31 ツォッヒェ，ミヒャエル 油除去装置を備えたエンジン
US5571515A (en) 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
HUP9901035A3 (en) 1996-02-28 2001-01-29 Bayer Healthcare Ag Parapoxviruses containing foreign dna, their production and their use in vaccines
EP0958364A4 (en) 1996-10-23 2001-10-31 Univ Pennsylvania IMMUNOTHERAPY AND IMPROVED Vaccines
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
BR9908267A (pt) 1998-02-27 2000-10-24 Univ Pennsylvania Plasmìdeo, composição farmacêutica, processos para induzir uma resposta imunológica em um indivìduo contra um imunógeno, para imunizar um indivìduo contra uma infecção por vìrus de herpes simples e para tratar um indivìduo que tem uma doença autoimune, vacina recombinante, e, patógeno atenuado vivo
CA2322232A1 (en) 1998-03-13 1999-09-16 American Home Products Corporation Lyophilized polynucleotide composition, method of preparation, and uses thereof
CN1197618C (zh) 1998-09-30 2005-04-20 惠氏控股有限公司 突变霍乱全毒素佐剂
AU782508B2 (en) 1999-11-08 2005-08-04 Biomune Vaccines for mycoplasma bovis and methods of use
US6548069B2 (en) 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin
GB0110851D0 (en) 2001-05-03 2001-06-27 Mini Agriculture & Fisheries Vaccine
KR100898648B1 (ko) 2001-06-07 2009-05-22 와이어쓰 홀딩스 코포레이션 보조제로서 콜레라 홀로톡신의 돌연변이체 형태
KR20080078717A (ko) 2001-06-07 2008-08-27 와이어쓰 홀딩스 코포레이션 보조제로서 콜레라 홀로톡신의 돌연변이체 형태
US20030147914A1 (en) 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
EP1601333B1 (en) 2003-02-20 2013-01-23 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services Novel insertion sites in pox vectors
US20090068231A1 (en) 2007-09-11 2009-03-12 Wyeth Live attenuated mycoplasma strains
CL2008003202A1 (es) * 2007-10-29 2009-11-27 Boehringer Ingelheim Vetmedica Inc Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
WO2010002537A1 (en) 2008-07-03 2010-01-07 Iowa State University Research Foundation, Inc. Cattle vaccines
WO2010051210A1 (en) 2008-10-31 2010-05-06 Boehringer Ingelheim Vetmedica, Inc. Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
AU2010215065B2 (en) * 2009-02-20 2014-05-15 Australian Poultry Crc Pty Limited Live attenuated vaccines
UY32570A (es) 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada

Also Published As

Publication number Publication date
PT3334454T (pt) 2022-12-20
EP4137152A1 (en) 2023-02-22
ES2933623T3 (es) 2023-02-10
EP3334454B1 (en) 2022-10-19
FR23C1037I1 (fr) 2023-12-08
BR112018002919B1 (pt) 2024-02-27
WO2017030901A1 (en) 2017-02-23
AU2016307935A1 (en) 2018-02-22
AU2022231761A1 (en) 2022-10-06
EP3334454A1 (en) 2018-06-20
US20190255166A1 (en) 2019-08-22
CN108135989B (zh) 2022-08-09
CN115141772A (zh) 2022-10-04
FI3334454T3 (fi) 2023-01-13
CA2995101A1 (en) 2017-02-23
CY1125699T1 (el) 2024-02-16
AU2016307935B2 (en) 2022-08-18
JP2018523708A (ja) 2018-08-23
BR112018002919A2 (pt) 2018-09-18
MX2018001841A (es) 2018-08-01
CY2023020I1 (el) 2024-02-16
JP6675484B2 (ja) 2020-04-01
NL301244I1 (nl) 2023-10-04
SI3334454T1 (sl) 2023-02-28
NL301244I2 (nl) 2023-11-01
CY2023020I2 (el) 2024-02-16
US11389518B2 (en) 2022-07-19
HUE060545T2 (hu) 2023-03-28
CN108135989A (zh) 2018-06-08
HRP20221440T1 (hr) 2023-02-03
US20220296694A1 (en) 2022-09-22
ZA201800956B (en) 2018-12-19
HK1251478A1 (zh) 2019-02-01
LT3334454T (lt) 2022-12-27
CN115141773A (zh) 2022-10-04
PL3334454T3 (pl) 2023-01-30
HUS2300032I1 (hu) 2023-10-28

Similar Documents

Publication Publication Date Title
DK3283625T3 (da) Nukleasemedieret genomeditering
DK3331869T3 (da) Muscarinagonister
DK3305788T3 (da) Janus-kinase-hæmmer
DK3277719T3 (da) Polypeptider
DK3331528T3 (da) Muskarinagonister
DK3360890T3 (da) Genterapi
DK3331529T3 (da) Muskarinagonister
DK3310450T3 (da) Olie-vand-separator
DK3270930T3 (da) Præeklampsi
DK3394281T3 (da) Gærcelle
DK3292136T3 (da) Penicillin-g-acylaser
DE112015006486A5 (de) Inkubationsrinne
DK3274482T3 (da) Stenborsknop
DK3318308T3 (da) Badmintonketsjer
DE112016005599A5 (de) Strahlungsgrill
DE112015005898A5 (de) Gurtschlossbringer
ES1140083Y (es) Descompatactador tetrafunción
DE102015206660A8 (de) Plattenaufteilanlage
DK3334454T3 (da) Mycoplasma-Bovis-sammensætninger
DE112016001124A5 (de) Spannschutz
FI11070U1 (fi) Kantojyrsin
DE102015000551A8 (de) Rotationszerstäuberturbine
DE102015226549B8 (de) Hybridheizmodul
FI11139U1 (fi) Piirikorttikokoonpano
FI11131U1 (fi) Muuttajalaitejärjestely